Alcoholic liver disease laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:
*Low potassium levels (hypokalemia)
*Low potassium levels (hypokalemia)
*Low magnesium levels (hypomagnesemia)
*Low magnesium levels (hypomagnesemia)
*Elevated index of red blood cell size; increased mean corpuscular erythrocyte volume (MCV)
*Elevated index of red blood cell size; increased mean corpuscular erythrocyte volume (MCV).<ref name="pmid18239988">{{cite journal |vauthors=Kazemi-Shirazi L, Veloso MP, Frommlet F, Steindl-Munda P, Wrba F, Zehetmayer S, Marsik C, Ferenci P |title=Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful? |journal=Wien. Klin. Wochenschr. |volume=120 |issue=1-2 |pages=25–30 |year=2008 |pmid=18239988 |doi=10.1007/s00508-007-0921-1 |url=}}</ref><ref name="pmid21451926">{{cite journal |vauthors=Das SK, Mukherjee S, Vasudevan DM, Balakrishnan V |title=Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease |journal=Singapore Med J |volume=52 |issue=3 |pages=175–81 |year=2011 |pmid=21451926 |doi= |url=}}</ref>
*Increased number of white blood cells (leukocytosis)
*Increased number of white blood cells (leukocytosis).
*Decreased number of platelets (thrombocytopenia)
*Decreased number of platelets (thrombocytopenia).<ref name="pmid18239988">{{cite journal |vauthors=Kazemi-Shirazi L, Veloso MP, Frommlet F, Steindl-Munda P, Wrba F, Zehetmayer S, Marsik C, Ferenci P |title=Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful? |journal=Wien. Klin. Wochenschr. |volume=120 |issue=1-2 |pages=25–30 |year=2008 |pmid=18239988 |doi=10.1007/s00508-007-0921-1 |url=}}</ref><ref name="pmid21451926">{{cite journal |vauthors=Das SK, Mukherjee S, Vasudevan DM, Balakrishnan V |title=Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease |journal=Singapore Med J |volume=52 |issue=3 |pages=175–81 |year=2011 |pmid=21451926 |doi= |url=}}</ref>
*Increased bilirubin levels, prolonged prothrombin time (PT) and decreased circulating albumin (hypoalbuminemia) are seen in alcoholic hepatitis and cirrhosis.
*Increased International Normalized Ratio (INR).<ref name="pmid18239988">{{cite journal |vauthors=Kazemi-Shirazi L, Veloso MP, Frommlet F, Steindl-Munda P, Wrba F, Zehetmayer S, Marsik C, Ferenci P |title=Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful? |journal=Wien. Klin. Wochenschr. |volume=120 |issue=1-2 |pages=25–30 |year=2008 |pmid=18239988 |doi=10.1007/s00508-007-0921-1 |url=}}</ref><ref name="pmid21451926">{{cite journal |vauthors=Das SK, Mukherjee S, Vasudevan DM, Balakrishnan V |title=Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease |journal=Singapore Med J |volume=52 |issue=3 |pages=175–81 |year=2011 |pmid=21451926 |doi= |url=}}</ref>
*Increased bilirubin levels, prolonged prothrombin time (PT) and decreased circulating albumin (hypoalbuminemia) are seen in alcoholic hepatitis and cirrhosis.<ref name="pmid21451926">{{cite journal |vauthors=Das SK, Mukherjee S, Vasudevan DM, Balakrishnan V |title=Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease |journal=Singapore Med J |volume=52 |issue=3 |pages=175–81 |year=2011 |pmid=21451926 |doi= |url=}}</ref>


==2010 AASLD/ACG Alcoholic Liver Disease Guidelines (DO NOT EDIT)<ref name="urlwww.aasld.org">{{cite web |url=http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/AlcoholicLiverDisease1-2010.pdf |title=www.aasld.org |format= |work= |accessdate=2012-10-27}}</ref>==
==2010 AASLD/ACG Alcoholic Liver Disease Guidelines (DO NOT EDIT)<ref name="urlwww.aasld.org">{{cite web |url=http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/AlcoholicLiverDisease1-2010.pdf |title=www.aasld.org |format= |work= |accessdate=2012-10-27}}</ref>==

Revision as of 21:52, 18 December 2017

Alcoholic liver disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alcoholic liver disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alcoholic liver disease laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alcoholic liver disease laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alcoholic liver disease laboratory findings

CDC on Alcoholic liver disease laboratory findings

Alcoholic liver disease laboratory findings in the news

Blogs on Alcoholic liver disease laboratory findings

Directions to Hospitals Treating Alcoholic liver disease

Risk calculators and risk factors for Alcoholic liver disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

It is important to take a complete history and find out about the patient's alcohol use and current signs and symptoms for alcoholic liver disease. As laboratory tests do not give the definitive diagnosis of alcoholic liver disease. It is also important to rule out other causes of liver disease such as, chronic viral hepatitis which could co-exist, autoimmune hepatitis, hemochromatosis and drug related hepatotoxicity. Initial assessment must include a complete blood count, hepatic panel (ALT, AST, bilirubin, GGT, alkaline phosphatase), INR and PT.

Laboratory Findings

Laboratory findings consistent with the diagnosis of alcoholic liver disease include:[1]

  • Elevated liver enzymes:[2]
    • Aspartate aminotransferase (AST) level will be greater than that of Alanine aminotransferase (ALT).
    • AST and ALT levels both will be below 300 IU/ml.
    • The key to diagnosis of alcoholic liver disease is that the AST to ALT ratio will be greater than 2.
  • Elevated levels of gamma glutamyltransferase (GGT) will indicate heavy alcohol use and may also indicate liver injury. This test is sensitive but not specific.[3]
  • Elevated triglyceride levels (hypertriglyceridemia).
  • Elevated uric acid levels (hyperuricemia)
  • Low potassium levels (hypokalemia)
  • Low magnesium levels (hypomagnesemia)
  • Elevated index of red blood cell size; increased mean corpuscular erythrocyte volume (MCV).[4][5]
  • Increased number of white blood cells (leukocytosis).
  • Decreased number of platelets (thrombocytopenia).[4][5]
  • Increased International Normalized Ratio (INR).[4][5]
  • Increased bilirubin levels, prolonged prothrombin time (PT) and decreased circulating albumin (hypoalbuminemia) are seen in alcoholic hepatitis and cirrhosis.[5]

2010 AASLD/ACG Alcoholic Liver Disease Guidelines (DO NOT EDIT)[6]

Laboratory Tests : Guidelines (DO NOT EDIT)[6]

Class I
1. " For patients with a history of alcohol abuse or excess and evidence of liver disease, further laboratory tests should be done to exclude other etiologies and to confirm the diagnosis. (Level of evidence: C) "

References

  1. Marsano LS, Mendez C, Hill D, Barve S, McClain CJ (2003). "Diagnosis and treatment of alcoholic liver disease and its complications". Alcohol Res Health. 27 (3): 247–56. PMID 15535453.
  2. Diehl AM (2002). "Liver disease in alcohol abusers: clinical perspective". Alcohol. 27 (1): 7–11. PMID 12062630.
  3. Moussavian SN, Becker RC, Piepmeyer JL, Mezey E, Bozian RC (1985). "Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease". Dig. Dis. Sci. 30 (3): 211–4. PMID 2857631.
  4. 4.0 4.1 4.2 Kazemi-Shirazi L, Veloso MP, Frommlet F, Steindl-Munda P, Wrba F, Zehetmayer S, Marsik C, Ferenci P (2008). "Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?". Wien. Klin. Wochenschr. 120 (1–2): 25–30. doi:10.1007/s00508-007-0921-1. PMID 18239988.
  5. 5.0 5.1 5.2 5.3 Das SK, Mukherjee S, Vasudevan DM, Balakrishnan V (2011). "Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease". Singapore Med J. 52 (3): 175–81. PMID 21451926.
  6. 6.0 6.1 "www.aasld.org" (PDF). Retrieved 2012-10-27.

Template:WS Template:WH